Closing the Observation Doesn't Always Solve the Problem
And this is why FDA is increasingly evaluating the management system behind the finding—not just the finding itself.
The belief that closing an FDA observation means the underlying problem has been solved has survived for decades.
It’s also one of the reasons remediation projects become far more expensive than they need to be.
The observation isn’t the problem. It’s simply where FDA happened to notice it.
That distinction matters because organizations under pressure naturally focus on what they can see. A procedure gets rewritten. Employees are retrained. A CAPA is opened and eventually closed. Documentation is updated. Everyone works hard, milestones are met, and the remediation project appears to be moving in the right direction.
Sometimes it is. But just as often, six or twelve months later, another inspection uncovers a remarkably similar weakness in a completely different part of the quality system.
Not because the previous remediation failed, but because the organization corrected the evidence of the problem without changing the management system that produced it.
That’s an easy trap to fall into. FDA observations are written around specific examples, and it’s human nature to respond to the example rather than the broader organizational behavior behind it. The result is remediation that improves individual records while leaving the underlying decision-making process largely untouched.
That’s becoming increasingly difficult to sustain under QMSR.
Investigators aren’t evaluating procedures as isolated pieces anymore. They’re following decisions as they move through design controls, risk management, supplier oversight, CAPA, complaints, management review, production activities, and post-market surveillance. When those connections don’t hold together, correcting one record rarely changes what FDA experiences during the next inspection.
In many ways, remediation has become less about fixing documents and more about restoring confidence that the quality management system consistently produces sound, risk-based decisions.
That requires a different conversation inside the organization.
Instead of asking, “How do we respond to this observation?” the more revealing question is often, “What allowed this situation to develop without anyone recognizing it sooner?”
Those questions lead to very different outcomes.
One produces a response letter.
The other changes how engineering, quality, regulatory, operations, and leadership evaluate decisions long before an investigator walks through the door.
That’s the kind of remediation that rarely attracts much attention.
It’s also the kind that tends to last.
